$380 Million is the total value of Endurant Capital Management LP's 63 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 104.5% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
SPY | Buy | SPDR S&P 500 ETF TRput | $46,022,000 | +58.8% | 101,900 | +67.3% | 12.12% | +73.3% |
CNC | Buy | CENTENE CORP DEL | $18,373,000 | +214.9% | 218,235 | +208.2% | 4.84% | +243.8% |
OFIX | Buy | ORTHOFIX MED INC | $14,218,000 | +2330.4% | 434,803 | +2210.7% | 3.74% | +2556.0% |
BMY | New | BRISTOL-MYERS SQUIBB CO | $14,218,000 | – | 194,684 | +100.0% | 3.74% | – |
SYNH | Buy | SYNEOS HEALTH INCcl a | $9,976,000 | +29.1% | 123,232 | +63.7% | 2.63% | +40.8% |
AVTR | Buy | AVANTOR INC | $9,669,000 | +114.4% | 285,901 | +167.2% | 2.55% | +134.1% |
BIO | Buy | BIO RAD LABS INCcl a | $9,660,000 | -12.1% | 17,151 | +18.0% | 2.54% | -4.0% |
MCK | New | MCKESSON CORP | $8,929,000 | – | 29,168 | +100.0% | 2.35% | – |
AZYO | Buy | AZIYO BIOLOGICS INC | $6,601,000 | -2.6% | 1,109,479 | +3.1% | 1.74% | +6.3% |
EW | New | EDWARDS LIFESCIENCES CORP | $5,246,000 | – | 44,561 | +100.0% | 1.38% | – |
ISRG | New | INTUITIVE SURGICAL INC | $5,199,000 | – | 17,232 | +100.0% | 1.37% | – |
EHC | New | ENCOMPASS HEALTH CORP | $4,669,000 | – | 65,653 | +100.0% | 1.23% | – |
OCUL | Buy | OCULAR THERAPEUTIX INC | $4,574,000 | -8.5% | 923,963 | +28.8% | 1.20% | -0.1% |
ADAP | Buy | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $4,451,000 | +32.2% | 2,160,890 | +140.7% | 1.17% | +44.5% |
SELB | Buy | SELECTA BIOSCIENCES INC | $4,246,000 | -38.7% | 3,451,958 | +62.6% | 1.12% | -33.0% |
AXSM | Buy | AXSOME THERAPEUTICS INC | $4,151,000 | +97.5% | 100,299 | +80.3% | 1.09% | +115.6% |
AHCO | Buy | ADAPTHEALTH CORP | $3,980,000 | +66.2% | 248,314 | +153.6% | 1.05% | +81.3% |
INSM | Buy | INSMED INC | $3,884,000 | +59.8% | 165,280 | +85.3% | 1.02% | +74.3% |
ALBO | Buy | ALBIREO PHARMA INC | $3,604,000 | +135.7% | 120,834 | +84.1% | 0.95% | +157.2% |
GLPG | New | GALAPAGOS NVspon adr | $3,250,000 | – | 52,400 | +100.0% | 0.86% | – |
IDXX | New | IDEXX LABS INC | $3,134,000 | – | 5,729 | +100.0% | 0.83% | – |
QGEN | New | QIAGEN NV | $2,727,000 | – | 55,656 | +100.0% | 0.72% | – |
PINC | New | PREMIER INCcl a | $2,692,000 | – | 75,632 | +100.0% | 0.71% | – |
STRO | Buy | SUTRO BIOPHARMA INC | $2,437,000 | +46.5% | 296,508 | +165.2% | 0.64% | +59.7% |
MTD | New | METTLER TOLEDO INTERNATIONAL | $2,424,000 | – | 1,765 | +100.0% | 0.64% | – |
FATE | Buy | FATE THERAPEUTICS INC | $2,316,000 | +6.0% | 59,732 | +60.0% | 0.61% | +15.7% |
TNDM | New | TANDEM DIABETES CARE INC | $2,121,000 | – | 18,236 | +100.0% | 0.56% | – |
KRTX | New | KARUNA THERAPEUTICS INC | $1,945,000 | – | 15,342 | +100.0% | 0.51% | – |
TXG | New | 10X GENOMICS INC | $1,896,000 | – | 24,923 | +100.0% | 0.50% | – |
BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $1,826,000 | +118.4% | 15,400 | +153.7% | 0.48% | +138.1% |
VRTX | New | VERTEX PHARMACEUTICALS INC | $1,822,000 | – | 6,982 | +100.0% | 0.48% | – |
ALNY | New | ALNYLAM PHARMACEUTICALS INC | $1,695,000 | – | 10,379 | +100.0% | 0.45% | – |
AFMD | New | AFFIMED N V | $1,549,000 | – | 354,492 | +100.0% | 0.41% | – |
VRDN | Buy | VIRIDIAN THERAPEUTICS INC | $1,539,000 | +15.5% | 83,217 | +23.4% | 0.40% | +25.8% |
GBT | Buy | GLOBAL BLOOD THERAPEUTICS IN | $1,498,000 | +19.6% | 43,250 | +1.1% | 0.40% | +30.8% |
ARGX | New | ARGENX SEsponsored adr | $1,413,000 | – | 4,480 | +100.0% | 0.37% | – |
RCUS | New | ARCUS BIOSCIENCES INC | $1,220,000 | – | 38,650 | +100.0% | 0.32% | – |
DVA | New | DAVITA INCput | $1,131,000 | – | 10,000 | +100.0% | 0.30% | – |
XBI | Buy | SPDR SER TRcall | $1,132,000 | -91.2% | 126,000 | +10.2% | 0.30% | -90.4% |
MTEM | Buy | MOLECULAR TEMPLATES INC | $1,084,000 | +3.0% | 314,238 | +17.1% | 0.29% | +12.6% |
CDNA | New | CAREDX INC | $1,037,000 | – | 28,048 | +100.0% | 0.27% | – |
IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $1,011,000 | -1.9% | 60,720 | +12.5% | 0.27% | +6.8% |
NTRA | New | NATERA INC | $1,007,000 | – | 24,747 | +100.0% | 0.26% | – |
KZR | New | KEZAR LIFE SCIENCES INC | $988,000 | – | 59,474 | +100.0% | 0.26% | – |
BDSX | New | BIODESIX INC | $221,000 | – | 130,753 | +100.0% | 0.06% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
LABORATORY CORP AMER HLDGS | 31 | Q2 2023 | 8.7% |
ELEVANCE HEALTH INC | 29 | Q3 2023 | 8.8% |
BECTON DICKINSON & CO | 28 | Q2 2023 | 9.8% |
MCKESSON CORP | 27 | Q1 2023 | 4.4% |
CENCORA INC | 26 | Q3 2023 | 5.9% |
HOLOGIC INC | 24 | Q3 2023 | 7.5% |
JOHNSON & JOHNSON | 24 | Q4 2021 | 5.5% |
ZIMMER HLDGS INC | 23 | Q3 2023 | 7.5% |
BOSTON SCIENTIFIC CORP | 22 | Q3 2023 | 5.5% |
DAVITA INC | 22 | Q1 2021 | 4.9% |
View Endurant Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
AZIYO BIOLOGICS, INC. | March 21, 2023 | 576,253 | 4.9% |
Oxford Immunotec Global PLCSold out | February 17, 2021 | 0 | 0.0% |
View Endurant Capital Management LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-07 |
SC 13D/A | 2024-04-10 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
SC 13D/A | 2023-09-08 |
13F-HR | 2023-08-14 |
3/A | 2023-05-24 |
13F-HR | 2023-05-15 |
3 | 2023-05-15 |
SC 13D | 2023-05-15 |
View Endurant Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.